Keep informed about the latest topics in global health.
#VaccinesWork
FOCUS AREAS African Vaccine Manufacturing Accelerator (AVMA) Zero-Dose Child Gavi Secretariat and leadership Progress report Partners Our Board
CAREERS Current vacancies Internship programme RFPs and consulting
Contact us ISO certification Phishing and fraud
SUPPORTED COUNTRIESDetailed information on each Gavi-eligible countryExplore our Country Hub
FOR COUNTRIES
Apply for support
Gavi 5.0 Ceilings by country and support type
OUR RESULTS
Evaluation studies
Facts and figures
Progress reports
African Vaccine Manufacturing Accelerator (AVMA)
COVID-19
The Global Vaccine Impact Conference explained
Read article
KEY AREAS
Donor profiles
Matching Fund
Pneumococcal AMC
FEATURED STORY
Everything you need to know about Gavi's incoming CEO, Dr Sania Nishtar
VACCINE PROFILES
Read series
KEY PUBLICATION
The 2023 Mid-Term Review Report
PROGRESS REPORT
24 April 2015
Gavi and the Global Fund welcome malaria vaccine trial results
Next five years vital for childhood immunisation - Gavi CEO
23 April 2015
Pakistan vaccinators' salaries
4 February 2015
Gavi commends donor support of life-saving work through IFFIm
11 December 2014
Dr Flavia Bustreo appointed Vice Chair of Gavi Board
Gunilla Carlsson appointed to Gavi Board
27 November 2014
Gavi thanks UK for commitment to help immunise a further 300 million children by 2020
25 November 2014
Chancellor Merkel calls for successful Gavi replenishment
1 November 2014
Pentavalent vaccine introductions represent historic milestone for immunisation in India
29 October 2014
Australia commits AUD 50 million to support immunisation in developing countries in 2015
28 October 2014
Review of Gavi support to Nigeria
17 October 2014
Tanzania to protect 21 million children against measles and rubella